(Q41641041)

5 October 2017

title

S100P and HYAL2 as prognostic markers for patients with triple-negative breast cancer (English)

1 reference

5 October 2017

10

1 reference

5 October 2017

12

Barbara Burwinkel

0 references

Andreas Schneeweiss

9

object named as

Andreas Schneeweiss

1 reference

5 October 2017

Melanie Maierthaler

1

1 reference

5 October 2017

Mark Kriegsmann

2

1 reference

5 October 2017

Cike Peng

3

1 reference

5 October 2017

Sarah Jauch

4

1 reference

5 October 2017

Akos Szabo

5

1 reference

5 October 2017

Markus Wallwiener

6

1 reference

5 October 2017

Joachim Rom

7

1 reference

5 October 2017

Christof Sohn

8

1 reference

5 October 2017

Rongxi Yang

11

1 reference

5 October 2017

publication date

22 June 2015

1 reference

Experimental and Molecular Pathology

5 October 2017

published in

1 reference

5 October 2017

volume

99

1 reference

5 October 2017

issue

1

1 reference

5 October 2017

page(s)

180-187

1 reference

Bcl2 is an independent prognostic marker of triple negative breast cancer (TNBC) and predicts response to anthracycline combination (ATC) chemotherapy (CT) in adjuvant and neoadjuvant settings

5 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Stratifying triple-negative breast cancer: which definition(s) to use?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Glycosaminoglycans: key players in cancer cell biology and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

S100P stimulates cell proliferation and survival via receptor for activated glycation end products (RAGE)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

S100P promotes pancreatic cancer growth, survival, and invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Characterization of the Ca2+ -regulated ezrin-S100P interaction and its role in tumor cell migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Elevated expression of S100P, CAPL and MAGE 3 in doxorubicin-resistant cell lines: comparison of mRNA differential display reverse transcription-polymerase chain reaction and subtractive suppressive hybridization for the analysis of differential gen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Increased hyaluronidase levels in breast tumor metastases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

BCL2 is an independent predictor of outcome in basal-like triple-negative breast cancers treated with adjuvant anthracycline-based chemotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

CD44 interaction with Na+-H+ exchanger (NHE1) creates acidic microenvironments leading to hyaluronidase-2 and cathepsin B activation and breast tumor cell invasion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Comprehensive molecular portraits of human breast tumours

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Triple-negative breast cancer: disease entity or title of convenience?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Hyaluronidase splice variants are associated with histology and outcome in adenocarcinoma and squamous cell carcinoma of the lung.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Triple-negative breast cancer: clinical features and patterns of recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Two novel functions of hyaluronidase-2 (Hyal2) are formation of the glycocalyx and control of CD44-ERM interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Biological subtypes of triple-negative breast cancer are associated with distinct morphological changes and clinical behaviour

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Purification and characterization of a new member of the S-100 protein family from human placenta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Expression and activity of articular cartilage hyaluronidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

RAGE activation by S100P in colon cancer stimulates growth, migration, and cell signaling pathways

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

CD44-dependent intracellular and extracellular catabolism of hyaluronic acid by hyaluronidase-1 and -2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Calcium-binding protein S100P and cancer: mechanisms and clinical relevance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Ki-67 can be used for further classification of triple negative breast cancer into two subtypes with different response and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

The calcium-binding protein S100P in normal and malignant human tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Molecular stratification of triple-negative breast cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Application of Angiogenic Oligosaccharides of Hyaluronan Increases Blood Vessel Numbers in Rat Skin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Enhanced S100 calcium-binding protein P expression sensitizes human bladder cancer cells to cisplatin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Unfavourable prognostic significance of S100P expression in ovarian cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

HYAL1 overexpression is correlated with the malignant behavior of human breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Human breast-cancer metastasis formation in a nude-mouse model: studies of hyaluronidase, hyaluronan and hyaluronan-binding sites in metastatic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

HYAL1 and HYAL2 inhibit tumour growth in vivo but not in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

Angiogenesis induced by degradation products of hyaluronic acid.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

DNA methylation array analyses identified breast cancer-associatedHYAL2methylation in peripheral blood

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2015.06.010

10.1016/J.YEXMP.2015.06.010

7 January 2021

Identifiers

DOI

1 reference

5 October 2017

1 reference